{
}
The biotech sector is experiencing a correction after a pandemic-driven surge, with venture capital focusing on mature companies and M&A activity expected to rise amid regulatory changes. Innovation thrives, particularly in targeted therapies like antibody-drug conjugates and radioligand therapy, as cancer centers adapt to new treatments. Despite challenges, the industry's future appears optimistic, driven by equity capital markets and technological advancements.
Andrew Lam
People
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Biotech Investment Trends Emerge Amid Market Corrections and Regulatory Changes
17:27 03.12.2024
Trending
Subcategory
Corporate News
Startups & Entrepreneurship
Economic Indicators
Global Trade Developments
Market Analysis and Predictions
Countries:
Companies:
Currencies:
People: